SABBADINI ROGER A.,GARLAND WILLIAM A.,STOLLER GLENN L.,SABBADINI Roger A.,GARLAND William A.,STOLLER Glenn L.
申请号：
SI200631487
公开号：
SI1948234T1
申请日:
2006.10.27
申请国别(地区):
SI
年份:
2013
代理人:
摘要：
The present invention relates to compositions and methods for the treatment of diseases and conditions, including ocular diseases and conditions, characterized by aberrant fibrogenesis or scarring, inflammation and/or aberrant neovascularization or angiogenesis. The compositions and methods of the invention utilize immune-derived moieties that are specifically reactive against bioactive lipids and which are capable of decreasing the effective concentration of the bioactive lipids. In some embodiments, the immune-derived moiety is a monoclonal antibody that is reactive against sphinxine-1-phosphate (S1P) or lysophosphophatidic acid (LPA).
